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851-3 Prognostic Implications of Ischemlc MItral 
Regurgitation in Patients With Myocardial Infarction 
Ramdas G. Pal, Padmini Varedarajan, VA Medical Center, Loma Linda, California. Loma 
Linda Universi~ Loma Linda, Cafifomia. 
Background: Mitral regurgitation (MR) is frequent in patients with myocardial infarction 
(MI). Prognostic importance of angiographicaUy detected MR is well documented. How- 
ever, angiography is performed in higher risk patients. Echocardiography on the other 
hand is more commonly performed in lower risk patients. But the prognostic implications 
of echocardiographically detected MR in the modern era is uncertain. 
Methods and results: The echocardiographic database search in our laboratory from 
1990 to 99 yielded 2623 patients who had evidence of MI (ie pathological Q waves) in 
concurrently obtained electrocardiograms - anterior in 668 and inferior in 2178 (both in 
460). MR by Framingham criteria was present in 1566 (60%) patients - trivial in 455 
(17%), mild in 796 (31%), moderate in 227 (9%) and severe in 88 (3%). Other patient 
characteristics: age 69(11) years, LV ejection fraction 46(16)%, 736 deaths over 3 years. 
Patients with trivial MR had a survival curve similar to those with no MR (5 year survival 
of 73%). However, surviva) was significantly lower in those with mild, moderate and 
severe degrees of MR (5 year survival 60, 49 and 30% respectively, p<0.0001 ). Deleteri- 
ous effect of MR was present in both anterior and inferior MI. There was a strong associ- 
ation between increasing degrees of MR and older age (p<0.0001), and lower EF 
(p<0.0001). Proportional hazards model identified MR (p=0.009) to be an independent 
correlate of survival after correcting for age and EF (both p<0.0001). 
Conclusions: 1) MR is frequent in MI and adversely affects prognosis. 2) It is related to 
age and LV dysfunction rather than MI location. 3) Its impact on mortality is independent 
of age and degree of LV dysfunction. 4) Even mild MR is a high risk indicator. 5) Optimal 
management of MR in MI warrants further investigations. 
11:15 a.m. 
851-4 Baseline Risk Predicts Therapeutic Efficacy Differences 
Between Coronary Bypass and Coronary Angioplesty 
Charaniit S. Rihal. Manuel S. Lombardero, Gabriel Silverman, Katherine M. Datre, 
Hartze[I V. Schaff, and Bernard J. Gersh for the BARI Investigators, Mayo Clinic and 
Foundation, Rochester, Minnesota, University of Pittsburgh, Pittsburgh, Pennsylvania. 
Background: The Bypass Angioplasty Revascularization Investigation (BARI) found that 
diabetes mellitus before ravasculadzation predicts differences between bypass surgery 
and angioplasty. The effects of more complex combinations of baseline factors have not 
been examined. We hypothesized that benefits of CABG over PTCA, if any, were propor- 
tional to baseline risk. 
Methods: Baseline risk for the BARI population (trial + registry) was estimated with a mul- 
tivariate risk score developed by the CABG Surgery Trialists Collaboration using a model 
to predict 10-year mortality. (Lancet 1994;344:563-70) that included both clinicaJ (age, 
angina, history of myocardial infarction, diabetes, hypertension, and ejection fraction) 
and angiographic (right coronary or proximal LAD lesion) variables. Pts were divided into 
quintiles of risk and long-term all-cause mortality differences assessed with the log-rank 
statistic. 
Results: 3610 pts (mean age 61.5 years, 74% male) were included in the analysis. 1517 
underwent CABG and 2093 PTCA, Vital status was available for 97% and mean follow 
up was 7.7 years. 
Conclusions: Baseline risk, as determined by an independently derived multivariable 
equation, accurately stratified pts. Observed long-term mortality at the highest levels of 
risk was lower after CABG compared to PTCA but equivalent at lower levels of risk. 
CABG is to be preferred over PTCA among high-risk pts, but either procedure is suitable 
at low and moderate levels of risk. 
Risk Quintile 1 2 3 4 5 
5-Year Mortality PTCA (%) 6.5 4.1 9.0 13.8 21.5 
5-Year Mortality CABG (%) 4.2 6.8 8.3 11.5 16.4 
P, Log-Rank Test NS NS NS 0.088 0.0204 
11:30 a.m. 
851-5 Report  o f  Erecti le Dysfunction After Therapy With Beta- 
Blockers Is Related to Patient Knowledge of Side 
Effects and is Reversed by Both Sildenafil Citrate and 
Placebo 
Giuseooe M. Rosano, Giuseppe Mercuro, Filippo Leonardo, Paolo Pagnotta, Roberto 
Pathzi, Massimo Fini, San Raffaele Hospital, Roma, Italy, University of Cagliad, Cagliad, 
Italy. 
Patients with cardiovascular diseases (CVD) frequently complain of erectile dysfunction 
especially when treated with beta-blockers. In order to assess whether the effect of beta- 
blockers on erectile dysfunction is, in part related to patient knowledge of the drug side 
effects 96 male patients with CVD entered a double-blinded parallel study. Thirty-two 
patients atenolol 50 mg (A) without knowledge of the drug they were administered, 32 
received A knowing that the drug was a beta-blocker and 32 received A knowing that the 
drug they were taking was a beta-blocker and that it could have given erectile dysfunc- 
tion. 
After 3 months patients were administered a quality of life questionnaire containing ques- 
tions about erection. 
The incidence of erectile dysfunction was 3% in the group not knowing which drug they 
were taking, 16% in the group knowing that they were receiving a beta-blocker and 30% 
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in the group also knowing the side effects of the drug (p<0.01). Patients reporting erectile 
dysfunction entered a double blind placebo controlled study on the effect of Sildenafil Cit- 
rate on the reversal of beta-blocker-induced erectile dysfunction. Sildenafil citrate and 
placebo were equally effective in reversing erectile dysfunction in all but one patient in 
whom only withdrawal of beta-blockade was effective in reversing erectiledysfunction.. 
In conclusion in male patients with CVD the report of erectile dysfunction after therapy 
with beta-blockers is largely related to patient knowledge of the drug side effects as it is 
almost always completely reversed by a placebo drug. 
11:45 a.rn. 
851-6 Gender Differences in Extent and Severity of Coronary 
Disease in the ACC National Cardiovascular Disease 
Registry 
Laslee J. Shaw, Raymond J. Gibbons, Ben McCallister, Kristi R. Mitchell, Kathleen 
Hewitt, Lloyd W. Klein, William S. Weintreub, Ralph G. Brindis, Richard E. Shaw, Atlanta 
Cardiovascular Research Institute, Atlanta, Georgia, Mayo Clinic, Rochester, Minnesota. 
Background: The evaluation of women (W) with suspected coronary disease (CAD) 
remains a difficult diagnostic dilemma due to varying presentation and test accuracy. 
Methods: A total of 43,629 elective diagnostic cardiac catheterizations performed for sta- 
ble symptoms or provocative ischamia in 184 hospitals in 1999-2000. Multivadable logis- 
tic regression models were used to estimate 1) significant (>=70% stenosis) and 2) 
severe CAD (3 vessel or left main). 
Results: W comprise 45% of patients and were older with more hypertension, diabetes, 
vascular disease, atypical angina, and heart failure symptoms. Significant and severe 
CAD rates were 30% and 7% in W and 48% and 15% in men (p<0.0001, see Table). In 
multivariable models, female gender was an independent predictor of significant (odds 
ratio[OR]=2.6, 95% C1=2.5-2.6, p<0.000t) and severe CAD (OR=2.5, 98% C1=2.3-2.7, 
p<0.0001 ). For W, significant CAD predictors were age, typical angina, vascular disease, 
hypertension, hypercholesterolemia, positive stress test, smoking, and diabetes 
(Z2=2769, p<0.OO01, r2=.16). Severe CAD predictors were age, typical angina, vascular 
disease, hypercholesterolemia, diabetes, and smoking (X2=768, p<O.O001, r2=.05). 
Conclusions: Due to lower rates of obstructive CAD in women, predictive algorithms and 
clinical guidelines should consider development of separate male and female diagnostic 
strategies for optimal disease detection including newer, more aggressive screening 
approaches for women. 
0 >0<50% 50-69% 1 Vessel 2 Vessel 3 Vessel or Left 
Stenosis Stenosis Stenosis CAD CAD Main CAD 
Women 48% 14% 8% 16% 7% 7% 
(n=19761) 
Men 32% 12% 8% 21% 12% 15% 
(n=23868) 
ORAL CONTRIBUTIONS 
852 Inflammatory Mechanisms of Myocardial 
Ischemia 
Tuesday ,  March  19 ,  2002,  10 :30  a .m. -Noon 
Georgia World Congress Center, Room 160W 
lO:3O a.m. 
852-1 Persistent Activation of the NF-K B Signaling Pathway 
in Pat ients  With Unstable Angina and Elevated Levels of 
C-Reactive Protein 
Giovanna Liuzzo. Matteo Santamaria, Francesca Ginnetti, Annalisa Porto, Dominick J. 
Angiolillo, Vittoria Rizzello, Luigi M. Biasucci, Cardiology, Catholic Universi~ Rome, Italy, 
Background: Elevated levels of C-reactive protein (CRP) are associated with an 
increased risk of persistent instability, death and myocardial infarction in patients with 
acute coronary syndromes. However, it is still unclear whether CRP is simply a marker of 
disease activity or a pathogenatic component of instability. Recent reports have sug- 
gested that CRP may amplify the response to other pro-inflammatory stimuli and that a 
specific activation of the nuclear transcription factor NF-K B may be involved in this pro- 
cess. The aim of the present study was to explore the contribution of the NF-K B signal- 
ing pathway to the enhanced inflammatory response observed in patients with unstable 
angina (UA). 
Methods: We studied 12 patients with history of UA and persistently elevated levels of 
CRP (>3mg/L), followed for 12 months and free of symptoms for at least 3 months, and 
12 patients with chronic stable angina (SA) and normal CRP. Freshly isolated peripheral 
blood monocytes (MO) were analyzed for spontaneous NF-K B activation by electro- 
phoretic mobility shift assay, and for IL-6 production after in vitro stimulation with low 
dose of lipopolysaccharide (LPS) (lng/mL, for 4 hours). 
Results: Evidence for NF-~< B signaling in vivo was provided by demonstrating the 
nuclear presence of NF-~ B complexes in MO freshly isolated from 9/12 (75%) UA ver- 
sus 2/12 (17%) SA patients (P=0.014). As expected, LPS-stimuiated IL-6 production 
(median, range) was significantly higher in UA (3.3 ng/ml, 2.5-7.9) than in SA (2.1 ng/ml, 
0.2-4.5) (P<0.01). In the overall population, IL-6 production in response to LPS was lin- 
eady correlated with baseline levels of CRP (r=0.49, P<0.01) and with the NF-I< B activa- 
tion status (r=0.39, P= 0.04). 
Conclusions: Circulating MO from UA patients with persistently elevated levels of CRP 
exhibit a specific activation of the nuclear transcription factor NF-E B, 3 months after the 
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last acute event. Such condition is associated with an enhanced responsiveness to pro- 
inflammatory stimuli. Thus, NF-K B activation might represent a mechanism by which 
CRP amplifies and perpetuates the inflammatory component of acute coronary syn- 
dromes. 
10:45 a,m. 
852-2 Widespread Coronary Inflammation In Patients With 
Unstable Angina 
Antonino Buffon. Luigi M. Biasucci, Giovanna Liuzzo, Gianloca Comerci, Giuseppe 
D'Onofrio, Filippo Crea, Attilio Maseri, Catholic Univerei~ Rome, Italy. 
Background: Inflammation may cause unstable angina (UA) by favoring coronary 
plaque rupture and erosion, In UA activated leukocytes were found in peripheral and cor- 
onary sinus blood, but it is unclear whether they are selectively activated in the vascular 
bed of the culprit stenosis, 
Methods: We measured the difference in neutrophil myeloperoxidase content (MPXI) 
across the cardiac and femoral circulation in 5 groups of patients: 33 with UA and single 
stenosis either in left descending (LAD) artery (UA-L, 24 patients) or right coronary artery 
(UA-R, 9 patients), 13 with stable angina, 13 with variant angina and 6 controls. Blood 
samples were taken simultaneously from aorta, femoral vein and great cardiac vein 
(GCV) which selectively drains LAD but not right coronary blood (as we confirmed by the 
presence or absence of evidence of vasodilation in the GCV following nitrates injection 
into left and right coronaries respectively), Plasma levels of C-reactive protein (CRP) 
were also measured. 
Results: Aortic MPXI was similar in UA-L and UA-R (-3.9 and -5.5), but significantly 
lower than in the other three groups (all P<O.05). A significant negative correlation was 
found between aortic MPXI and CRP values (r=-0.45, P=0,025), MPXI significantly 
decreased in GCV both in UA-L (-6.4, P<0.O01) and UA-R (-6.6, P=0.003), but not in sta- 
ble angina with LAD stanosis, variant angina with LAD ischemia, or controls. No MPXI 
decrease was observed in any group in the femoral vein, The GCV-aorta gradient was 
also significantly correlated with CRP levels (r=-0.41, P=0,011 ). 
Conclusions: The widespread inflammatory activation of neutrophils across the COro- 
nary vascular bed, independent of culprit stenosis location and of ischemia, carries 
important pathophysiologicel implications and challenges the concept of a single coro- 
nary vulnerable plaque in unstable coronary syndromes. 
11:00 a.m. 
852-3 Apoptosls Resistance of Nautrophils in Patients With 
Unstable Angina 
Luioi M. Biasucci, Annalisa Porto, Claudia Colussi, Donetella Lomaglio, Francesca 
Raimondi, Laura Morlacchi, Francesca Ginnetti, Giovanna Liuzzo, Attilio Maseri, 
Cardiology, Catholic Universi~ Rome, Italy 
Background: Activated neutrophils have been found in the peripheral and coronary cir- 
culation of pts with unstable angina (UA). As apoptosis limits neutrophils pro-inflamma- 
tory functions, we hypothesized that a prolonged survival of peripheral neutrophils could 
represent one of the inflammatory mechanisms leading to instability. 
Methods: We investigated spontaneous apoptosis of circulating neutrophils in 31 pts 
with Braunwald class IIIB UA, 12 pts with stable angina (SA) and 32 normal subjects (N). 
Peripheral blood samples were taken within 12 hours from the last ischaemic episode; 
neutrophils were isolated by gradient cantrifugation (Polymorphprap, N/corned) and cul* 
tured at 37°C. Spontaneous apoptosis of neutrophUs was analyzed by flow cytometry 
using Annexin V-FITC (Immunotech, Marseille, France) at 4, 20 and 48 hours after isola- 
tion. CRP was also measured by a high-sensitivity method (Dede-Behering). 
Results: Data are reported as median (range).The apoptotic rate was significantly lower 
in UA vs SA and N at 4 hours: the percentage of apoptotic neutrophils was 11% (2-41) in 
UA, 45% (6-75) in SA and 29% (13-82) in N (p<0.01, UA vs SA and N). The apoptotic 
delay persisted in UA pts at 20 and 48 hours, being at 20 hours 72% (40-86) in UA, 76% 
(28-94) in SA, 83% (61-96) in N ( p<0.01 UA vs N) and at 48 hours 84% (38-98) in UA, 
87% (67-97) in SA and 95% (47-100) in N (p<0.05 UA vs N). In the overall population, a 
significant negative correlation was seen between CRP levels and the apoptotic rate at 4 
hours ( r= -27, p<0.01). 
Conclusion: Our study demonstrates a significant neutrophil apoptosis resistance in pts 
with UA. A prolonged survival of peripheral neutrophils suggests that an enhanced pro- 
inflammatory potential of these cells may represent a novel mechanism of instability. 
11:15 a.m. 
852-4 C-Reactive Protein-Mediated Complement Activation 
During Acute Myocardial Infarction in Humans 
Wire K. Laorand, Remco Nijmeijer, Hans W. Niessen, Cses A. Vissar, Wim T. Hermens, 
Yvonne P. Lubbers, Machiel J. van Eenige, Aart J. Karreman, C.Erik Hack, VU Medical 
Centre, DpL of Cardiology, Amsterdam, The Nether~ands, CLB, Sanquin Blood Supply 
Foundation, Amsterdam, The Nether~ands. 
Background 
Complement activation during acute myocardial infarction (AMI) may contribute to a 
worse course, and is a potential target for therapy. The mechanism of complement acti- 
vation during AMI is still unclear, but likely involves C-reactive protein (CRP), as this 
acute phase protein is present in infarcted human myocardium together with activated 
complement fragments, and CRP was found to increase infarct size in a rat model of AMI 
via complement activation. We, therefore, examined CRP-mediatad complement activa- 
tion in blood samples of humans with AMI or unstable angina pectoris (UAP), 
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Methods 
CRP-complement complexes (CRP-C3d and CRP-C4d), specific markers for CRP- 
dependent complement activation, were measured in serial plasma samples of patients 
with AMI (n=82) or UAP (n=25). Peak levels and cumulative generation of the complexes 
in time were related to those of complement activation fragments (C3a, C3b/c, and C4b/ 
c), enzymatic infarct size and clinical course. 
Results 
Peak levels and cumulative generation of complement activation fragments during the 48 
hours-observation peried were significantly higher in patients with AMI than in those with 
UAP. Complement activation during the first 12 hours was significantly higher in AMI 
patients treated with thrombolysis than in patients treated with direct angioplasty. The 
generation of CRP-camplement complexes also was significantly higher in patients with 
AMI than in patients with UAP. The 48 hours-cumulative release of CRP and generation 
of CRP-C4d complexes correlated significantly with enzymatic infarct size, and was most 
pronounced in AMI patients without raparfusion therapy. Complement fragments, CRP 
and CRP-complement complex levels did not differ between patients with or without 
adverse events during 1-year follow-up, but were found to be associated with these 
adverse events, when using a merit value (= (sensitivity + specificity) - 100%) of >50%. 
Conclusions 
Complement activation after AMI is, in part, mediated by human CRP, and is influenced 
by the use of thrombolytic agents and occurrence of reperfusion. This activation is asso- 
ciated with a higher incidence of cardiovascular events after AMI during 1-year follow-up. 
11:30 a.m. 
852-5 aPLA2 Potentiates Binding of CRP to Ischemlcally 
Challenged Card lomyocytea  
Remoo Niimeiier, Hans W. Niessen, Cees A. Visser, Yvonne P. Lubbers, Caspar G. 
Schalkwijk, Erik C. Hack, Free University Medical Hospital (VU), Amsterdam, The 
Netherlands, Sanquin Blood Supply Foundation (C.L.B), Amterdam, The Netherlands. 
Introduction: Myocardial infarction induces a systemic and local inflammatory response. 
Recently we found co-local/sing depositions of C-raactive protein (CRP) and secretory 
Phospholipase A2 (sPLA2) in human infarcted myocardium: sPLA2 occupying a larger 
area than CRP. We hypothesize that sPLA2 may be involved in the formation of suitable 
ligands for binding of CRP to infarcted cardiomyocytes. We have studied this in adult rab- 
bit cardiomyocytes and H9C2 ceils. 
Materials: Adult rabbit cardiomyocytes were isolated by collagenase perfusion of the 
heart. H9C2 calls were cultured according to ATCC guidelines. CRP was isolated from 
human ascites. While sPLA2 was isolated from HEPG2 cells by means of affinity chro- 
matography. The activity of sPLA2 was validated. Ischemia was mimicked by means of 
metabolic buffer. Subsequent to ischemia cells were reperfused with or without sPLA2 
and/or CRP. Cell vitality was evaluated using Propidium Iodide (PI) and Annexin-V (AV) 
staining. Binding of CRP or sPLA2 to the cells was evaluated by means of fluorescence 
immunohistochemistry. 
Results: After exposure of the cells to metabolic inhibition a rapid decline in cell vitality 
evolved. Both in adult cardiomyocytes and H9C2 cells sPLA2 positivity was found in AV 
and PI double positive cells (thus late apoptotic or necrotic cells). Interestingly sPLA2 
positivity was also found in single AV positive calls (thus early apoptotic or flip-flopped 
but viable cells). H9C2 cells exposed to metabolic inhibition showed increased capacity 
to bind sPLA2 and CRP when exposed for a period of two hours to culture medium con- 
taining these molecules. The binding of CRP in the metabolic inhibited group was mainly 
to PI positive (non-viable) cells. However, in ischemically challenged cells previously 
exposed to sPLA2 the binding of CRP was significantly higher when compared to the 
cells not pra-incubatad with sPLA2. 
Conclusion: These findings support (1) sPLA2 binds to viable but ischemic cardiomyo- 
cytes. (2) sPI.A2 potentiated binding of CRP to ischemic cardiomyocytes. Our findings 
therefore are in line with our hypothesis that inflammatory mediators increase the the 
area of infarction subsequent to myocardial infarction. 
11:45 a.m. 
852-6 C-Reactive Protein Elevation Following Chemically 
Induced Septal Infarction in Humans Without Coronary 
Atherosclerosis 
David H. Lewis, Patricia A, Gum, Fred Van Lanta, E. Murat Tuzcu, Harry Lever, Mid 
America Heart Institute, Kansas Ci~ Missouri, The Cleveland Clinic Foundation, 
Cleveland, Ohio. 
Background: C-reactive protein (CRP) elevation predicts major adverse cardiac events in 
healthy individuals, patients with stable angina pectoris, patients with acute coronary 
syndromes, and in patients undergoing percutaneous and surgical revascularization. 
Percutaneous transluminal septal ablation in hypertrophic ardiomyopathy (HCM) allows 
for measurement of the CRP response to myocardial infarction (MI) without the con- 
founding influence of an unstable coronary plaque. 
Methods: Eleven patients with HCM and without angiographic evidence of coronary ath- 
erosclerosis undergoing septal ablation were studied. Myocardial infarction was induced 
by infusing alcohol into septal perforating arteries. Blood was obtained at baseline and at 
48 hours, High sensitivity CRP analysis was carried out by immunonephelometry, using 
an Immage analyzer (Beckman Coulter). 
Results: Baseline CRP values were available on 7 patients, Mean CRP at baseline was 
0.42 ± 0.37 mg/dl (normal <1.0 mg/dl). CRP values at 48 hours were available on all 11 
patients. Mean CRP at 48 hours was 6.84 ± 2.39 mg/dl. For the patients with values 
obtained both at baseline and at 48 hours, there was a sixtaenffold increase in CRP 
observed (p<0.0005). 
Conclusions: These data represent the first analysis of the dramatic CRP elevation fol- 
